Symbol
SNDX on Nasdaq
Investment type
Equity / COMMON STOCK
Latest Disclosed Shares Owned
2,040,013 shares
Security Ownership %
2.4%
Shares, Excluding Options vs Price
Value, Excluding Options

Morgan Stanley ownership in Syndax Pharmaceuticals Inc COMMON STOCK (SNDX)

07 May 2025 - Morgan Stanley has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 2,040,013 shares of Syndax Pharmaceuticals Inc COMMON STOCK (SNDX). This represents 2.4% ownership of the company. In their previous filing dated 05 Feb 2025, MORGAN STANLEY had reported owning 5,362,169 shares, indicating a decrease of +62%. .
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.